Enterprise Software Investors & VC Firms in Europe
308 firms in this list, with a median first check of $500K. 14 of them lead rounds. Generated from verified public data and updated continuously.
TEV Ventures
EssenSeed–Series B$7.6M
9 people
Wallonie Entreprendre
LiégeSeed–Late Stage
9 people
Whiz Partners Inc.
TokyoSeed–Late Stage$500K – $5M
6 people
115K
ParisSeed–Series B$270K – $5.4M
5 people
Alicorn Venture Partners
LondonGrowth$1M – $15M
5 people
Arts Alliance
LondonSeed–Late Stage$540K – $5.4M
5 people
Backed
LondonSeed$540K – $2.7M
5 people
Basinghall Partners
LondonSeed–Series A$540K – $5.4M
5 people
Delta Partners
DublinSeed–Series A$108K – $3.2M
5 people
DEPO Ventures
Prague 7Pre-Seed–Series A$54K – $324K
5 people
Emerge
LondonPre-Seed–Series A$635K – $3.2M
5 people
Empower Capital
SofiaSeries A–Series B$270K – $3.2M
5 people
Frumtak Ventures
ReykjavikSeed–Late Stage$1M – $3M
5 people
G+D Ventures
MunichSeed–Series B$216K – $2.2M
5 people
GR Capital
LondonGrowth$3.2M – $10.8M
5 people
HEARTFELT_
BerlinPre-Seed–Series A
8 people
Innovation Nest
KrakowSeed–Series A$108K – $1.1M
5 people
Kennet Partners
LondonGrowth–Late Stage$8.6M – $32.4M
5 people
Nasdaq Ventures
New YorkSeed–Series B$2M – $5M
5 people
Neulogy Ventures
BratislavaSeed–Series A$216K – $3.2M
5 people
NEVEQ Capital Partners Ltd.
SofiaSeed–Series B$324K – $3.2M
5 people
OXO Ventures
BudapestSeed–Series B$216K – $5.4M
5 people
Phoenix Contact Innovation Ventures
BlombergSeed–Late Stage$108K – $2.7M
5 people
Practica Capital
VilniusPre-Seed–Series A$324K – $3.2M
5 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Enterprise Software Series A Investors & VC Firms (1523)Enterprise Software Seed Investors & VC Firms (1492)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)
Data sourced from public filings and firms' own websites — see our methodology.